Bio-Techne Corporation (TECH) Stock Analysis

Bio-Techne Corporation (TECH) Stock Analysis — AI Research | MarketCI

TECH

Market Closed

Bio-Techne Corporation

NASDAQHealthcare Biotechnology

3.10K employees

CEO: Kim Kelderman

Founded: 1989

$57.94

+$0.00(+NaN%)

Market Cap

9.07B

Beta

1.36

52W Range

N/A

Dividend Yield

0.55%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

TECH Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for TECH built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$22.78

AI Price Target

Machine learning • Price prediction

$55.53

Market Sentiment

News & social media analysis

0.04

Value Investor Price

Classic value analysis

$9.93

Financial Health

Bankruptcy risk assessment

11.32

Quality Score

Financial strength rating

8.00

AI Investment Grade

Deep analysis of filings & news

72.00

Key Investment Highlights

Important factors affecting TECH investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

58.54% Good

Conditions Met

24.00/41.00

Due Diligence Score

58.54%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Fail
	Pass
	Fail
	Pass

Showing 1 to 6 of 46 conditions